EPTIS
BAM Logo

Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2)

[EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)]

EPTIS factsheet 935187 | Last revision 2022-05-12 | URL: https://www.eptis.bam.de/pts935187 https://www.eptis.bam.de/pts935187

PT provider
PT provider ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda
Based in Brazil
Language(s) Portuguese/ English / Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Medical analysis
Biology
Technical details
Test item Tested property Testing method
lyophilized human serum RDT - Neutralizing Antibody Research: Coronavirus (SARS-CoV2) Routine methods of participants
Aims of the PT scheme
Target group of participants No restrictions.
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Variable costs. For this information, please contact Controllab.
Regularly operated Yes (4 rounds per year)
Year of first operation 2021
Contact details of the PT provider
Provider Contact person
ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br http://www.controllab.com.br
Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: eptis@controllab.com eptis@controllab.com
If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr José Ricardo Bardellini da Silva. Mr José Ricardo Bardellini da Silva.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5